Wednesday, June 18, 2014

A New York Times opinion section "debate" about Truvada and so-called "Pre-Exposure Prophylaxis" or "PrEP."

In one of their "Room for Debate" features, The Opinion Pages of The New York Times 

June 17 chose five mostly HIV-AIDS Industry likely suspects to "debate" use of Gilead's toxic chemotherapy Truvada for so-called "PrEP."
Is a Pill Enough to Fight H.I.V.?
It wasn't much of a "debate," more akin to: "French fries: possibly fattening, pretty much OK, or really f'king great?"  The missing position:"You're poisoning yourself, stupid!"